 |
|
 |
Actionable Insights to the Evolving Management of MS: Important Considerations in Improving Outcomes
Provided by: ASiM
The introduction of treatments designed to change the natural disease course of multiple sclerosis (MS) has focused attention on the economic burden of this disease. Economic evaluations, which analyze the burden of MS on society and the cost effectiveness of new therapies, stress that the economic burden of a disease should be seen in a global per... |
|
The Rheumatoid Arthritis Landscape: An Update for Managed Care and Specialty Pharmacists
Provided by: ASiM
Rheumatoid arthritis (RA) is a disabling autoimmune disease that causes pain, stiffness, swelling, and limitation of motion in multiple joints, as well as inflammation in other organs. An estimated 1.3 million Americans are affected. Traditionally, RA has been treated with synthetic disease-modifying antirheumatic drugs (DMARDs) and nonsteroidal an... |
 |
Avoiding Medication Errors with Insulin Therapy
Provided by: Academy of Managed Care Pharmacy
Description:
Avoiding Medication Errors with Insulin Therapy is a knowledge-based program for pharmacists and nurses. The activity will explore the history of errors associated with insulin therapy and review the frequency with which they occur. Participants will learn how medication errors are generally multifactorial in nature and how medication... |
 |
Managing Chronic Noncancer Pain with Opioids - A Case Approach for the Pharmacists
Provided by: The CE Solution, Inc.
The goal of this activity is to enable pharmacists to apply the latest information about chronic pain management to improve the treatment of patients with chronic noncancer pain requiring use of opioids for an extended duration while minimizing the potential for inappropriate use of the medication.
Accreditation:... |
 |
Implementing Barcode Technology to Improve Medication Safety
Provided by: ProCE
Medication errors in hospital settings have been associated with high rates of adverse drug reactions and even death. Technological advances, such as barcode scanners, can help prevent medication errors, having been shown to reduce the medication error rate in an ICU setting by 56%. This educational program will review the root problem of medicatio... |
 |
Managing Drug Interactions with Warfarin
Provided by: The Collaborative Education Institute
Learning Objectives:
Upon successful completion of this program, pharmacists should be able to:
1. Identify factors that contribute to the high prevalence of warfarin drug interactions.
2. Describe the typical time course for warfarin drug interactions.
3. Describe mechanisms for warfarin drug interactions.
4. Discuss various types of drugs or... |
 |
A Review of Asbestos and Related Consequences
Provided by: U.S. Pharmacist
After completing this activity, participants should be able to:
1. Discuss the origin of asbestos and its impact on health.*
2. Identify the risk factors and etiology of asbestos-related diseases.*
3. Differentiate between various asbestos-related diseases.*
4. Provide information on the current regulation of asbestos.*
5. Recognize... |
|
PCA: 25 Years in the Making: Where Are We Now?
Provided by: ProCE
Upon completion of this activity, pharmacists and nurses will be able to:
* Describe quality improvement models for PCA and the role of nursing and pharmacy in these models
* Discuss pain management in the acute care and ambulatory environment
* Integrate the management of risks associated with PCA use and adequacy of analgesia
* Identify the f... |
 |
Multiple Sclerosis in Managed Care: Managing Decisions and Shaping Health Outcomes
Provided by: ASiM
Multiple sclerosis (MS) is a costly disease in terms of its effects on patients’ quality of life and its financial cost to society. The introduction of treatments that are designed to change the natural disease course has focused attention on the economic burden of MS. Balancing cost-effective treatment with current guidelines and optimal therapy... |
|
Optimizing Disease Control to Manage RA-Associated Pain in Adults
Provided by: U.S. Pharmacist
This accredited activity is targeted to pharmacists and pharmacy technicians. Estimated time to complete this activity is 120 minutes.
GOAL:
To review the pathophysiology of rheumatoid arthritis (RA) and discuss pharmacologic and nonpharmacologic options for managing pain associated with RA in adults.
OBJECTIVES:
After completing this acti... |
 |
Diabetic Neuropathy
Provided by: Ohio Northern University
Description:
Diabetic neuropathy is a heterogeneous disease state in which prevention and therapy must be individualized. Diabetic neuropathy is a complication that will continue to increase in prevalence in the future. As healthcare practitioners, we have a duty to educate patients how to minimize their risk for developing diabetic neuropathy a... |
|
Hyperthyroidism: Exploring Treatment Strategies
Provided by: U.S. Pharmacist
After completing this activity, the participant should be able to:
1.Explain the biosynthesis, transport, and control of thyroid hormones.*
2.Discuss the etiology and diagnosis of hyperthyroidism.*
3.Review treatment options for hyperthyroidism.*
4.Develop an individualized pharmacotherapy and monitoring plan for the management of hyperthyr... |
 |
HIPAA Privacy Training for the Pharmacy Workforce (v4)
Provided by: Ohio Pharmacists Association
Key to learning objectives:
* P = Pharmacist
* T = Technician
At the successful completion of this course, you will be able to:
* Describe the definition of HIPAA and explain the effects on pharmacy workplace. [P]
* Describe what HIPAA is and what it affects. [T]
* Identify HIPAA basics, including Covered Entities and Protected ... |
|
Building the bridge to partnership: Fostering the community and managed care pharmacy relationship
Provided by: Academy of Managed Care Pharmacy
Description:
Discover how managed care organizations and community pharmacists are working together to help advance medication therapy management services.... |
 |
Health Insurance Advanced Studies, Part A online course.
Provided by: America's Health Insurance Plans
You understand the health insurance industry and continuously work to stay ahead of the trends and changes. This online course advances your knowledge on a full range of topics within health insurance including health insurance plan structures and alternatives, prescription drugs, and pharmacy benefit news, Medicare and Part D, Medicaid, tax treatm... |
 |
New Drugs for Glycemic Control in Type 2 Diabetes Mellitus
Provided by: Pharmacy Society of Wisconsin
1. Explain the epidemiology and burden of diabetes in Wisconsin and the United States.
2. Compare and contrast current glucose control treatment recommendations for patients with type 2 diabetes.
3. Analyze the therapeutic rationale of bromocriptine and colesevelam for diabetes.
4. Summarize the role of incretin-enhancing therapies and their pot... |
|
Pharmacotherapeutic Management of Chronic Hepatitis C Infection
Provided by: Pharmacy Society of Wisconsin
1. Discuss the current epidemiology and trends of hepatitis C virus (HCV) infection as well as identify key viral transmission modes and their associated risk factors.
2. Describe the natural progression of liver disease associated with HCV and how host, viral, transmission and environmental factors affect disease progression.
3. Discuss the burd... |
 |
Preventing Fraud, Waste & Abuse in Pharmacy Practice -Specialized & CE Exam
Provided by: Pharmacy Foundation of California
This assessment will be used to evaluate your mastery of content provided in Preventing Fraud, Waste & Abuse -2010 Update.... |
|
Expanding the Treatment Armamentarium for Non-Small-Cell Lung Cancer: Pharmacist Perspectives
Provided by: ASiM
Lung cancer is the leading cause of cancer-related mortality in the United States, accounting for more than 200 000 new cancer cases and more than 150 000 cancer-related deaths each year. Non–small-cell lung cancer (NSCLC) accounts for more than 85% of lung cancer cases, and is usually associated with a poor prognosis. Health-system pharmacists p... |
|
Ethics for Preceptors
Provided by: The Collaborative Education Institute
Learning Objectives:
Upon successful completion of this activity, pharmacist preceptors should be able to:
1. Given a practice-related issue, discern if an ethical problem is present.
2. Define and apply the following principles to clinical practice issues: respect for autonomy, beneficence, nonmaleficence, justice and fidelity.
3. Given an eth... |
|
Pharmacy Law
Provided by: Pharmacy Society of Wisconsin
Goal: To help pharmacy technicians understand and identify the major legal rules and regulations dealing with the practice of pharmacy.... |
|
HIPAA Security Basics for the Pharmacy Workforce
Provided by: Pharmacy Foundation of California
This course reviews administrative, physical, and technical safeguards mandated by the HIPAA Security requirements; describes required policies and procedures; and introduces the basic concepts of information security.... |
 |
Is it Possible to Significantly Limit or Halt the Damage from Rheumatoid Arthritis (RA)? — The Benefits of Anti-TNF Therapy in Managed Care
Provided by: Impact Education, LLC
TARGET AUDIENCE
This activity has been designed to meet the educational needs of managed care pharmacists, pharmacy directors, medical directors, quality directors, policy executives, managed care affiliated physicians, employer and government policy administrators, and other managed care administrators.
STATEMENT OF NEED
The advent of the ant... |
 |
Evidence Based Treatment of Heart Failure, Anticoagulation, and Pain Management
Provided by: University Learning Systems
Session 1 – Wednesday, August 8, 2012 - An Evidence-Based Heart Failure Review
Session 2 – Thursday, August 9, 2012 - A Comprehensive, Evidence-Based Review of Anticoagulation
Session 3 – Friday, August 10, 2012 - A Comprehensive, Evidenced-Based Review of Treating Pain and Suffering
... |
 |
Managing Joint Pain and Associated Conditions
Provided by: Power-Pak C.E.®
To provide pharmacists with an update on the newer approaches to the management of osteoarthritis and provide strategies for educating, counseling, and monitoring patients about the relief of joint pain.... |
|
Preceptor Development Core Modules
Provided by: The Collaborative Education Institute
Activity Description:
This knowledge-based continuing pharmacy education activity will equip preceptors with the background information they need to be successful clinical instructors for pharmacy students.... |
|
Assisting Students in Migraine Management
Provided by: The Collaborative Education Institute
Learning Objectives:
Upon successful completion of this activity, pharmacists should be able to:
1. Discuss the prevalence of migraine and the societal impact in terms of disability, work loss, and health care expenditures.
2. Review the current understanding of migraine's pathophysiology
3. Describe validated tools to improve screening and dia... |
|
Preventing Fraud, Waste & Abuse in Pharmacy Practice -Specialized
Provided by: Ohio Pharmacists Association
At the completion of this program, you should be able to:
* Explain the federal regulations related to fraud, waste and abuse
* Describe how Medicaid & Medicare fraud, waste and abuse regulations affect your daily work
* Describe the components of your company's fraud, waste and abuse compliance program
* State your responsibi... |
|
Shifting Paradigms in Type 2 Diabetes: Managed Care Perspectives
Provided by: ASiM
Affecting over 11% of the adult US population, type 2 diabetes mellitus (T2DM) is a chronic and disabling disease that is associated with substantial morbidity from both macro- and microvascular complications. It is the leading cause of kidney failure, nontraumatic lower-limb amputations, and new cases of blindness among American adults, and is a m... |
|
Tapentadol IR: A Gain for Pain?
Provided by: The Collaborative Education Institute
Learning Objectives
1. Describe the mechanism of action of tapentadol immediate release (IR).
2. Determine the appropriate dose and dosing schedule for tapentadol IR.
3. Recognize tapentadol IR's contraindications, warnings and precautions.
4. Identify adverse effects that have been associated with tapentadol IR.
5. Discuss potential drug-drug... |
|
|
Virtual Exhibits / Booths
Join Email List
Visit Our Website
View Literature
